41 results
Page 2 of 3
6-K
ikrkpp9j3mk ysa90fgy
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
y9wwkwp3
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm
6-K
EX-99.2
fq19ej
19 Nov 18
Agreement and Plan of Merger
4:34pm
6-K
EX-99.1
obrt6 nj0zo8j
24 Oct 16
Bioblast Announces Results of Trehalose Clinical Study
12:00am
424B5
uwbsndzi7em8v r6uew5
18 Mar 16
Prospectus supplement for primary offering
12:00am
6-K
EX-99.2
pjczhhj5gksnc24dvl
27 Oct 15
Current report (foreign)
12:00am
6-K
EX-99.1
joss03n5 yn1
27 Oct 15
Current report (foreign)
12:00am
20-F
mw1y6dsi
31 Mar 15
Annual report (foreign)
12:00am
6-K
EX-99.1
me0dlpuurcd
10 Feb 15
Notice of Extraordinary General Meeting of Shareholders
12:00am
6-K
EX-99.1
nt4rled78q9jvu
8 Jan 15
Current report (foreign)
12:00am
6-K
EX-99.1
yealo80igvek9
22 Sep 14
Bio Blast Pharma Announces Initiation of its Canadian OPMD Clinical Study Center at McGill University, Montreal
12:00am
6-K
EX-99.1
zkiry21mmdg bhbi8
17 Sep 14
BioBlast Pharma Announces Preclinical and Clinical Pharmacokinetic Results with Cabaletta, Interim Safety Results from Phase 2/3HOPEMD Study in OPMD
12:00am
424B4
zj5s60yfe
31 Jul 14
Prospectus supplement with pricing info
12:00am